Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
about
Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR DysregulationThe rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?Cholangiocarcinoma: Current Knowledge and New DevelopmentsMolecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein.Targeting cholangiocarcinoma.
P2860
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@ast
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@en
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@nl
type
label
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@ast
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@en
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@nl
prefLabel
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@ast
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@en
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@nl
P2860
P3181
P1476
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
@en
P2093
Lewis R. Roberts
Mitesh J. Borad
P2860
P3181
P356
10.1097/MOG.0000000000000171
P407
P577
2015-05-01T00:00:00Z